explore -WSS

explore

author：entertainment 2025-09-06 03:28:27 - browse：78

Miniature people figurines standing in a group looking down. -- health tech coverage from STAT — Adobe

In less than two years, digital health’s high-flying class of public debuts have landed with a resounding thud.

Accelerated by the pandemic’s forced adoption of telehealth and other digital health solutions, 2021 saw more than 30 health technology startups go public, raising hundreds of millions and in some cases billions of dollars. Today, three members of the class of 2021 have gone bankrupt. Twelve companies have lost more than 90% of their initial value, including Bright Health Group, Cue Health, and Better Therapeutics. And dangerously low reserves have inspired desperate moves to slash costs, drum up liquidity, and find buyers.

Most recently, the bankruptcy of digital primary care company Babylon Health has drawn attention to the plight of newly-public health tech companies, and how the froth of dealmaking at the height of the pandemic led to overblown valuations. Before its debut in June 2021, Babylon was valued at $4.2 billion; after filing for bankruptcy in August, its U.K. telemedicine business was sold for just over $600,000.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Teach medical students about patients with intellectual disabilities

focus

WSS

Roche to buy Carmot Therapeutics, developer of obesity drugs

Biotech stock slump in 2023: awaiting the turnaround

Microbiome research is starting to find links to chronic diseases

Medical student insurance fails on mental health care coverage

Teach medical students about patients with intellectual disabilities

In diabetes hearing, Sanders takes on a new foe: food makers

entertainment

explore

explore

Malaria cases in Florida and Texas: Here’s what you need to know

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Teach medical students about patients with intellectual disabilities

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Thermo Fisher plant for manufacturing gene therapies to expand

Tori Bowie and the unacceptable rates of Black maternal death

AI models in health care face new federal disclosure requirements

George Santos makes 1st court appearance after pleading not guilty to 13 counts

FDA needs staff influx to meet gene therapy needs, Marks says

Wikipedia

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

Patients' immediate access to test results puts radiologists in a bind

What PEPFAR has meant on the ground in Ukraine

CMS should re

Medical student insurance fails on mental health care coverage

After sickle

leisure time

focus

leisure time

hotspot